Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: GlobeNewswire
MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced a leading provider, Success TMS, has reached an impressive milestone delivering over 235,000 NeuroStar transcranial magnetic stimulation (TMS) treatments to patients across the U.S, in just 3 short years. Founded by Jonathan Michel in 2018 after the loss of his sister to suicide, Success TMS opened its flagship location in South Florida in 2018. The practice has since expanded to over 30 treatment centers in six states, providing more than 235,000 treatments to patients with Major Depressive Disorder (MDD) using NeuroStar Advanced Therapy – a non-drug and non-invasive treatment that stimulates areas of the brain that are underactive in depression.1,2 This treatment milestone, achieved in less than three yea
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital [Yahoo! Finance]Yahoo! Finance
- New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalGlobeNewswire
- Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression [Yahoo! Finance]Yahoo! Finance
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Neuronetics, Inc. (NASDAQ: STIM) had its "market perform" rating re-affirmed by analysts at William Blair.MarketBeat
STIM
Earnings
- 3/5/24 - Beat
STIM
Sec Filings
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- 4/1/24 - Form SC
- STIM's page on the SEC website